Abstract: A method and apparatus for indicating uplink reference signal information are provided. The method includes: indicating uplink reference signal information to a terminal through a signaling. The uplink reference signal information includes at least one of the following information: a transmission manner in which the terminal transmits an uplink reference signal, a transmission resource used by the terminal to transmit the uplink reference signal, a type of the uplink reference signal transmitted by the terminal, a cell identifier (ID) used by the uplink reference signal, and a virtual cell ID used by the uplink reference signal. Further provided in the embodiments of the present disclosure is a storage medium.

Abstract: A wireless High Definition Multimedia Interface (HDMI) transmitting device includes a wireless transmitting module and an HDMI interface configured to connect to a source device. The HDMI interface includes a power pin configured to receive power from the source device and a data pin configured to receive an HDMI data from the source device. The wireless transmitting module includes a power receiving contact connected to the power pin and a data receiving contact connected to the data pin. The wireless transmitting module receives the power through the power receiving contact and converts the HDMI data received by the data receiving contact into a wireless signal. Therefore, the wireless HDMI transmitting device may be powered in the absence of a power adapter, the space occupied by the wireless HDMI transmitting device is reduced, and a socket interface corresponding to the power adapter is not needed.

Abstract: Embodiments of the present disclosure disclose a method and apparatus for recognizing a body movement. A specific embodiment of the method includes: sampling an input to-be-recognized video to obtain a sampled image frame sequence of the to-be-recognized video; performing key point detection on the sampled image frame sequence by using a trained body key point detection model, to obtain a body key point position heat map of each sampled image frame in the sampled image frame sequence, the body key point position heat map being used to represent a probability feature of a position of a preset body key point; and inputting body key point position heat maps of the sampled image frame sequence into a trained movement classification model to perform classification, to obtain a body movement recognition result corresponding to the to-be-recognized video.

Abstract: A light guiding assembly and a fabricating method, a backlight module, and a display device are provided. The light guiding assembly includes a waveguide layer, and a coupling grating structure including at least two gratings, wherein at least one of the at least two gratings is located inside the waveguide layer, and orthographic projections of the at least two gratings on a surface of the waveguide layer at least partially overlap, the coupling grating structure being configured such that incident light propagates in the waveguide layer.

Abstract: Disclosed are calibration apparatuses for fluorescent microscopy instruments and methods of making and using them. Specifically, disclosed are calibration apparatuses with a fluorescent layer, such as photoresist, deposited on a substrate, with an optional layer of a reflective material, such as chrome. Illumination of the fluorescent and/or reflective layers, and detection and analysis of the resulting emissions allows evaluation of the instrument with respect to both reflective and fluorescent channels. Selection of appropriate fluorescent materials for the one or more fluorescent layers allows the evaluation of an instrument with respect to different fluorophores, as would be used with an instrument capable of two color detection.

Abstract: Provided are a pixel structure, a mask, and a display device. The pixel structure includes a plurality of pixel groups arranged in an array. Each of the pixel groups includes a first pixel sub-group and a second pixel sub-group disposed adjacent to each other in a first direction. Each of the first pixel sub-group and the second pixel sub-group includes sub-pixels of three different colors, and each of the first pixel sub-group and the second pixel sub-group includes at least two sub-pixels having a same color and arranged consecutively.

Abstract: Provided in this disclosure are oxidative dehydrogenation catalysts that include a mixed metal oxide having the empirical formula: Mo1.0V0.12-0.49Te0.05-0.17Nb0.10-0.20Od wherein d is a number to satisfy the valence of the oxide. The oxidative dehydrogenation catalyst is characterized by having XRD diffraction peaks (2? degrees) at 22±0.2, 27±0.2, 28.0±0.2, and 28.3±0.1. The disclosure also provides methods of making the catalysts that include wet ball milling.

Abstract: This invention relates to extracellular protein-protein interactions and their possible therapeutic uses. More particularly, this invention describes the interaction between Draxin, particularly fragments binding to ?-Netrins comprising SEQ ID NO.:1, 2 or 3, and variants thereof, with ?-Netrins, and the use of this interaction to disrupt ?-Netrin/Netrin receptor interactions. The invention also relates to diagnostic and/or therapeutic uses of Draxin or fragments or variants thereof, as well as to an antibody against Draxin inhibiting binding of Draxin to ?-Netrins. Further, the invention relates to fragments of ?-Netrins, in particular Draxin-binding Netrin1-fragments comprising SEQ ID NO.: 51 and variants thereof, as well as to an antibody against ?-Netrins inhibiting binding of ?-Netrins to Netrin receptors.

Abstract: An online system receives content items from a third party content provider. For each content item, the online system inputs an image into a neural network and extracts a feature vector from a hidden layer of the neural network. The online system compresses each feature vector by assigning a label to each feature value representing whether the feature value was above a threshold value. The online system identifies a set of content items that the user has interacted with and determines a user feature vector by aggregating feature vectors of the set of content items. For a new set of content items, the online system compares the compressed feature vectors of the content item with the user feature vector. The online system selects one or more of the new content items based on the comparison and sends the selected content items to the user.

Abstract: There is disclosed techniques for use managing data storage. In one embodiment, endurance values are generated in connection with a plurality of solid state drives (SSDs). Each endurance value for an SSD indicating an estimated number of write operations that may be performed on the SSD before the SSD wears out and requires replacement. Additionally, storage space is reserved on one or more of the SSDs such that an endurance level associated with the endurance value of the SSD will have an inverse relationship with the amount of storage space reserved on the SSD.

Abstract: The present invention discloses a method for lowering an oil pipe in a gas well without well-killing, a soluble bridge plug and a material preparation method thereof, wherein, the method comprises the steps of: lowering a bridge plug in a wellbore such that the bridge plug blocks the wellbore at a predetermined location in the wellbore; injecting water in the wellbore after the pressure in the wellbore has been relieved so as to replace gases in the wellbore; and lowering an oil pipe in the wellbore to the location of the bridge plug. The method for lowering an oil pipe in a gas well without well-killing, the soluble bridge plug and the material preparation method thereof provided in the present invention successfully solve the problem of high cost for lowering an oil pipe under pressure after a fracturing fluid has been injected into the casing.

Abstract: The present invention provides new compositions and methods for treating prostate cancer, e.g., drug-resistant prostate cancer, such as anti-androgen drug (e.g., enzalutamide) resistant and/or castration resistant prostate cancer (CRPC). These new compositions include, but are not limited to, pharmaceutical compositions that include an AR-V7 inhibitor, such as niclosamide. Alternatively, these new compositions can include, but are not limited to, pharmaceutical compositions that include an AKR1C3 inhibitor, such as indomethacin. These new methods include, but are not limited to, methods of administering an AR-V7 inhibitor, such as niclosamide, and/or an AKR1C3 inhibitor, such as indomethacin, to treat patients having prostate cancer. The present invention also provides methods of inhibiting androgen receptor variant expression, e.g. AR-V7, and methods of killing cells expressing AR-V7.

Abstract: Embodiments of the present invention disclose a method for adding an authentication algorithm program, and a relevant device and system, where the method includes: receiving, by an SM-DP+ server, an authentication algorithm program sent by an MNO, where the authentication algorithm program corresponds to target information, and the target information is at least one of: firmware version information of an eUICC, an EID issuer identifier of the eUICC, platform/operating system version information of the eUICC, or capability information of the eUICC; and generating, by the SM-DP+ server, a bound profile package that includes the authentication algorithm program, and sending the bound profile package to the eUICC by using an LPA. As can be learned, the eUICC can add the authentication algorithm program into the eUICC in time by implementing the authentication algorithm program described in a first aspect.

Abstract: A user equipment, base station and method for transmitting semi-persistent channel state information (SP-CSI) on a physical uplink shared channel (PUSCH) are provided. The user equipment includes processing circuitry configured to receive a control signaling message the control signaling message configuring the user equipment with at least one SP CSI report configuration on the PUSCH, and the message identifying a SP CSI reporting periodicity. The user equipment also receives physical layer control signaling identifying and activating the at least one SP CSI report configuration. Transmitter circuitry is configured to transmit a plurality of SP CSI reports, the reports being transmitted with the periodicity and according to the physical layer control signaling and the control signaling message.

Abstract: Provided in this disclosure are catalyst compositions. The catalyst compositions include an oxidative dehydrogenation catalyst that includes a mixed metal oxide having the empirical formula: Mo1.0V0.12-0.49Te0.05-0.17Nb0.10-0.20AlcOd wherein c is from 0 to 2.0 and d is a number to satisfy the valence of the oxide. The compositions are at least 40 wt. % amorphous as measured by XRD. The disclosure also provides methods of making the compositions.

Abstract: Disclosed are nucleic acid oligomers, including amplification oligomers, capture probes, and detection probes, for detection of Zika virus nucleic acid. Also disclosed are methods of specific nucleic acid amplification and detection using the disclosed oligomers, as well as corresponding reaction mixtures and kits.

Abstract: The present disclosure relates to polymorphic forms of the compound methyl (3R,6S)-6-amino-sulfonylamino-1-(thiazol-2-yl)-3-(2,3,4-trifluorophenyl)-3,5,6,7-tetrahydropyrrolo[1,2-c]pyrimidin-4-formate (compound 1). The present disclosure further relates to a pharmaceutical composition and pharmaceutical use and a preparation method of the polymorphic forms of compound 1.

Abstract: Embodiments of the present application disclose a method and a device for quickly inserting a recognized word. The method comprises: opening a to-be-edited document, acquiring a picture acquisition instruction of a user, acquiring a picture containing a required word, recognizing the required word in the picture in first document editing software, and moving the required word into a to-be-edited document. By using the method provided by the embodiment of the present application, work efficiency can be improved.

Abstract: Disclosed is a lens device, including: a first transparent substrate; a second transparent substrate; and a liquid crystal layer filled therebetween. The first transparent substrate is a Fresnel lens, and a surface of the Fresnel lens toward the liquid crystal layer is disposed with grooves which are spaced from one another in accordance with Fresnel wave zones. The second transparent substrate is configured to control state of a liquid crystal, such that a refractive index of the liquid crystal, when polarized light incident into the liquid crystal passes through the liquid crystal, transforms between a first refractive index of the liquid crystal and a second refractive index of the liquid crystal, wherein the first refractive index is greater than the second refractive index, and a refractive index of the Fresnel lens is substantially equal to the first refractive index of the liquid crystal in the liquid crystal layer.

Abstract: A drug decocting container comprises a cover body (1), an inner-layer container, and an outer-layer container. The inner-layer container is em-bedded in the inner part of the outer-layer container, the strength of the outer-layer container is larger than that of the inner-layer container, and the outer-layer container supports the inner-layer container and controls deformation of the inner-layer container. The cover body (1) is connected with the inner-layer container in a sealing way to form a sealed cavity, and a liquid inlet and a liquid outlet are provided on the sealed cavity. An inner pipe (3) is supported by a high-strength outer pipe (2) in the drug decocting container, such that the wall thickness of the inner pipe (3) can be thin, thereby reducing costs of the inner pipe (3), providing a condition for disposable use of the inner pipe (3), and preventing drugs from influencing each other by residues in the inner pipe (3) so as to affect the quality of a beverage while decocting different drugs.